Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Ottawa Marriott Hotel

Oct 29, 2018 7:00 AM - Oct 29, 2018 5:30 PM

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

Canadian Pharmacovigilance and Risk Management Strategies Conference

Session 1: What’s New and What’s Hot: Perspective on Pharmacovigilance and Risk Management

Session Chair(s)

Marc  Poitras, PhD, MBA

Marc Poitras, PhD, MBA

Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau

Health Canada, Canada

In this session, representatives from regulatory agencies and the industry will discuss the progress of the implementation of new/ongoing national, international initiatives to strengthen pharmacovigilance and risk management activities.


Tarek  Hammad, MD, PhD, MS, MSc, FISPE

Overview of Benefit-Risk Assessment in Medical Product Development: Context for Patient Engagement

Tarek Hammad, MD, PhD, MS, MSc, FISPE

Takeda, United States

Vice President, Head of Medical Safety, Marketed Products

Rhonda  Kropp, BSN, MPH

Optimizing Canada’s Health Product Vigilance Approach: An Update

Rhonda Kropp, BSN, MPH

Health Canada , Canada

Director General, Marketed Health Products Division

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.